Hamps Bio Limited (BOM:544312)

Market Cap	230.35M
Revenue (ttm)	71.20M +3.0%
Net Income	-1.63M
EPS	-0.14
Shares Out	8.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Open	26.05
Previous Close	25.19
Day's Range	26.05 - 26.44
52-Week Range	13.36 - 35.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Hamps Bio

Hamps Bio Limited provides pharmaceutical, freeze dried, and frozen products in India and internationally. The company offers nutrition supplement, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ready to eat food, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. The company sells its products under the HA...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 75
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544312

Financial Performance

In fiscal year 2025, Hamps Bio's revenue was 66.69 million, an increase of 2.99% compared to the previous year's 64.75 million. Earnings were 2.98 million, a decrease of -40.53%.